50mg Clavaseptin Palatable Tablet - per Tablet
157818
50mg Clavaseptin is used for the treatment or adjunctive treatment of periodontal infections caused by bacteria susceptible to amoxicillin in combination with clavulanic acid. VET PRESCRIPTION REQUIRED
Product Features
- Pack Size: - Sold Individually
- Target Animal: - Dogs and Cats
- Pet Prescription Required?: - Yes (For UK Orders)
- Active Ingredient: - Amoxicillin and Clavulanic Acid
- Product Name: - 50mg Clavaseptin Palatable Tablet - per Tablet
More Information
Description
This medication may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase this item if you have or are in the process of arranging such a prescription. See information bar for further details.
Clavaseptin is available in three tablet strengths: Clavaseptin 50mg Palatable Tablets containing 40mg Amoxicillin (as trihydrate) and 10mg Clavulanic Acid (as potassium salt). For use in cats and dogs. Clavaseptin 250mg Palatable Tablets containing 200mg Amoxicillin (as trihydrate) and 50mg Clavulanic Acid (as potassium salt). For use in dogs. Clavaseptin 500mg Palatable Tablets containing 400mg Amoxicillin (as trihydrate) and 100mg Clavulanic Acid (as potassium salt). For use in dogs. Excipient: Brown Iron Oxide (E172)
Uses in dogs: treatment or adjunctive treatment of periodontal infections caused by bacteria susceptible to amoxicillin in combination with clavulanic acid i.e. Pasteurella spp Streptococcus spp and Escherichia coli.
In cats: treatment of skin infections (including wounds and abscesses) caused by bacteria susceptible to amoxicillin in combination with clavulanic acid i.e. Pasteurella spp Staphylococcus spp Streptococcus spp and Escherichia coli.
Dosage and administration
The recommended dose of Clavaseptin Palatable Tablets is 10 mg amoxicillin/2.5mg clavulanic acid/kg twice daily by the oral route in dogs and cats according to the following table. Bodyweight (kg) 50mg tablets 1 tablet per 5kg bodyweight every 12h 250mg tablets 1 tablet per 20kg body weight every 12h 500mg tablets 1 tablet per 40kg bodyweight every 12h [1.0-2.0] � [2.1-4.0] 1 [4.1-6.0] 1� [6.1-8.0] 2 [8.1-10] � [10.1-20] 1 [20.1-30] 1� [30.1-40] 2 1 [40.1-60] 1� [60.1-80] 2 Duration of treatment: - 7 days for the treatment of periodontal infections in dogs - 7 to 14 days for the treatment of skin and soft tissue infections in cats To ensure the correct dosage bodyweight should be determined as accurately as possible to avoid under-dosing. Administration is made easier by the palatable nature of the tablet.
Contra-indications warnings etc
Do not use in case of hypersensitivity to penicillins or other substances of the �-lactam group. Do not administer to gerbils guinea pigs hamsters rabbits and chinchillas. Caution is advised in the use of Clavaseptin in any other small pet (non food-producing) herbivores. Use of the product should be based on susceptibility testing. Vomiting and diarrhoea may be observed. Treatment may be continued depending on the severity of the undesirable effect observed and a benefit/risk evaluation by the veterinary surgeon. Hypersensitivity reactions (allergiv skin reactions anaphylaxis) may be observed. In these cases administration should be discontinued and a symptomatic treatment given. In animals with impaired liver and kidney function the use of the product should be subject to a risk/benefit evaluation by the veterinary surgeon and the posology evaluated carefully. The safety of the product has not been established during pregnancy and lactation. Laboratory studies in rats have not produced any evidence of teratogenic foetotoxic or maternotoxic effects. Use the product only accordingly to the benefit/risk assessment by the responsible veterinarian. The bactericidal activity of amoxicillin may be reduced by the simultaneous use of bacteriostatic substances such as macrolides tetracyclines sulfonamides and chloramphenicol. At three times the recommended dose for a period of 28 days diarrhoea was observed in dogs. In the event of an overdose symptomatic treatment is advised. Operator warning Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection inhalation ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. 1. Do not handle this product if you know you are sensitised or if you have been advised not to work with such preparations. 2. Handle this product with great care to avoid exposure taking all recommended precautions. 3. If you develop symptoms following exposure such as skin rash you should seek medical advice and show the doctor this warning. Swelling of the face lips or eyes or difficulty in breathing are more serious symptoms and require urgent medical attention. Wash hands after handling the tablets Pharmaceutical precautions Do not store above 25�C. Store in the original package. Any unused product or waste material should be disposed of in accordance with national requirements.
Legal category
Clavaseptin is a POM-V (Pet Prescription Required)